Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention

NCT02035631 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2014-01-14

No results posted yet for this study

Summary

The main purpose of our study is to assess the effect of a lifestyle intervention combining weight control, diet and physical activity on the risk of recurrences among breast cancer patients with non-metastatic tumours in terms of 5-year cumulative incidence of recurences.

Conditions

  • Breast Neoplasms
  • Recurrence

Interventions

BEHAVIORAL

Diet

The dietary component, aimed to reduce calorie intake according to individual requirements, will be structured in 1-hour weekly sessions led by trained nutritionists. Sessions will concentrate on teaching participants about food groups, the food pyramid and Mediterranean diet, how to chose, prepare and cook hypo-caloric meals.

BEHAVIORAL

Physical activity

The physical activity component will include two sessions per week led by trained physical activity monitors including aerobic exercise of high/moderate intensity, and instruction about the at-home exercise activities (3 more sessions).

BEHAVIORAL

Minimal diet intervention

Some basic diet recommendations

BEHAVIORAL

Minimal physical activity intervention

Some basic recommendations on physical activity

Sponsors & Collaborators

  • Institut Català d'Oncologia

    lead OTHER

Principal Investigators

  • Beatriz Cirauqui Cirauqui, MD · Fundació Institut d'Investigació Germans Trias i Pujol

  • Sonia Del Barco Berron, MD · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

  • Vanesa Ortega Cebrián, MD · Hospital Vall d'Hebron

  • Maria Angeles Arcusa Lanza, MD · Consorci Sanitari de Terrassa

  • Antonio Agudo, MD · Institut Català d'Oncología - L'Hospitalet (ICO)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035631 on ClinicalTrials.gov